Status:
ACTIVE_NOT_RECRUITING
Evaluating the Effectiveness of Various Iron Salts in Oral Iron Therapy for Iron Deficiency and Anemia in Healthy Adults
Lead Sponsor:
Liaquat University of Medical & Health Sciences
Conditions:
Iron Deficiency
Iron Deficiency Anemia
Eligibility:
All Genders
18-50 years
Phase:
NA
Brief Summary
Oral iron supplements are a cornerstone therapy for treating iron deficiency and iron deficiency anemia, aiming to replenish low iron levels in the body. These supplements typically contain various ir...
Detailed Description
This multicenter, randomized, double-blind parallel-group, clinical trial study aims to conduct a comparative analysis of the effectiveness of oral ferric maltose, vs Sucrosomial iron. The study seeks...
Eligibility Criteria
Inclusion
- Healthy Adults aged 18-65 years
- Iron deficiency, defined as low serum iron \<50 µg/dL, ferritin \<20 ng/mL, and TIBC \>400 µg/dL.
- Able and willing to provide informed consent
- Willing to comply with oral supplementation and study follow-up
Exclusion
- Severe anemia, defined as hemoglobin (Hb) \<8 g/dL, requiring urgent intervention
- Known malabsorption syndromes (e.g., celiac disease, IBD)
- Active bleeding or blood transfusion within the past 3 months
- Pregnancy or lactation
- Use of iron supplements within the past 4 weeks
- Known allergy or intolerance to oral iron formulations
Key Trial Info
Start Date :
July 17 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2025
Estimated Enrollment :
59 Patients enrolled
Trial Details
Trial ID
NCT05985070
Start Date
July 17 2023
End Date
June 30 2025
Last Update
April 16 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Hospital
Lahore, Punjab Province, Pakistan, 54000
2
DHQ Hospital Narowal
Narowal, Punjab Province, Pakistan, 51600
3
Civil Hospital Kotri Distt Jamshoro
Kotri, Sindh, Pakistan, 76000